0
0.5
1
1.5
2+
Mortality
33%
Improvement
Relative Risk
Clinical improvement
-2%
primary
Days to clinical improv..
-6%
Viral clearance
44%
Favipiravir Alattar et al. EARLY TREATMENT
Is early treatment with favipiravir beneficial for COVID-19?
PSM retrospective 774 patients in Qatar (May - July 2020)
Improved viral clearance with favipiravir (p=0.0000014)
c19early.org
Alattar et al., J. Infection and Publi.., Nov 2021
Favors favipiravir
Favors control